Sakibul Huq received his BS from the University of North
Carolina at Chapel Hill in 2014 and an MD from Johns Hopkins University School
of Medicine in 2021. He is a Neurosurgery Resident at the Department of
Neurological Surgery, University of Pittsburgh. His research interests mainly
focus on skull base neurosurgery, neuro-oncology, cerebrovascular neurosurgery,
radiosurgery, general neurosurgery, quality improvement, high-value care,
medical education, and socioeconomics.
Milena Mattioli received her bachelor’s degree in Biology/Biological
Sciences from the University of Eastern Piedmont in 2016, a master’s degree in
Medical Biotechnology and Molecular Medicine from the University of Milan in
2018, and a Ph.D. in Molecular and Experimental Medicine from Humanitas
University, Milan. She is a Postdoc Researcher in the Brain Tumor
Nanotechnology Lab at UPMC Hillman Cancer Center. Her research interests and
experience mainly focus on advanced drug delivery methods for the treatment of
malignant brain tumors.
Dr. Alexandros Bouras received his Medical Degree (MD) from the University of Athens Medical
School in Athens, Greece. He completed his residency in General Surgery at
Metaxa Cancer Hospital in Piraeus, Greece, and his residency in Neurological Surgery at Tzanio
General Hospital in Piraeus, Greece. He is currently a Senior Research Scientist
and the Lab Manager of the Brain Tumor Nanotechnology Laboratory at the
University of Pittsburgh Medical Center Hillman Cancer Center in the Department
of Neurosurgery. Dr. Bouras’ main research interests focus on the application of magnetic hyperthermia therapy and photodynamic
therapy for the targeted imaging and therapy of patient-based glioma models
both in cell culture and rodent models. Moreover, he is actively
investigating the delivery of therapeutics in the brain by convection-enhanced
delivery, as well as the use of focused ultrasound for either the sonodynamic
therapy of malignant brain tumors or blood–brain barrier opening for the enhanced
systemic delivery of therapeutics in the brain. Finally, he is heavily involved
in the study of combination therapies for both the radiosensitivity
and chemosensitivity enhancement of malignant gliomas.
Constantinos G. Hadjipanayis received his BA from the
University of Delaware in 1994, an MD from the Sydney Kimmel Jefferson Medical
College in 1998, and a PhD in Biochemistry/Molecular Genetics from the
University of Pittsburgh in 2005. He is an executive vice-chair for the
University of Pittsburgh Neurological Surgery and director of the UPMC Center for
Image-Guided Neurosurgery (CIGNS) and serves as Co-Director of the department’s
Brain Tumor Program. He also directs the Brain Tumor Nanotechnology Laboratory
at the Hillman Cancer Center. His research interests mainly focus on the surgical
management of brain and spinal cord tumors; stereotactic radiosurgery (Gamma
Knife- and LINAC-based); fluorescence-guided neurosurgery; laser-interstitial
thermal therapy (LITT); intraoperative awake/cortical mapping; and
neuroendoscopy.
